Naseem Amin is Director of Bellerophon Therapeutics, Inc.. Currently has a direct ownership of 291,865 shares of BLPH, which is worth approximately $11,674. The most recent transaction as insider was on Jun 07, 2023, when has been sold 47,578 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 292K
0% 3M change
0% 12M change
Total Value Held $11,674

Naseem Amin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 07 2023
BUY
Grant, award, or other acquisition
-
47,578 Added 14.02%
291,865 Common Stock
Feb 10 2023
BUY
Grant, award, or other acquisition
-
84,000 Added 25.59%
244,287 Common Stock
Dec 31 2021
BUY
Grant, award, or other acquisition
-
39,032 Added 19.58%
160,287 Common Stock

Also insider at

AVDL
AVADEL PHARMACEUTICALS PLC Healthcare
NA

Naseem Amin

Director
Warren, NJ

Track Institutional and Insider Activities on BLPH

Follow Bellerophon Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLPH shares.

Notify only if

Insider Trading

Get notified when an Bellerophon Therapeutics, Inc. insider buys or sells BLPH shares.

Notify only if

News

Receive news related to Bellerophon Therapeutics, Inc.

Track Activities on BLPH